KCTD21-AS1: A Potential Drug Target and Biomarker (G100289388)

Target Name: KCTD21-AS1

NCBI ID: G100289388

KCTD21-AS1

Other Name(s): KCTD21 antisense RNA 1 | KCTD21-AS1 variant 1 | KCTD21 antisense RNA 1, transcript variant 1

KCTD21-AS1: A Potential Drug Target and Biomarker

KCTD21-AS1 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. Its unique structure and expression pattern have led to its potential as a drug target or biomarker.

The protein KCTD21-AS1 is composed of 21 amino acid residues and has a calculated molecular weight of 18.5 kDa. It is expressed in a variety of tissues, including the brain, heart, and liver, and has been shown to localize to specific cellular compartments in these tissues.

One of the key features of KCTD21-AS1 is its localization to the endoplasmic reticulum (ER) and its subsequent degradation in the trans Golgi fraction. This localization to the ER and trans Golgi fraction suggests that KCTD21-AS1 may be involved in the delivery and degradation of proteins across the membrane of the endoplasmic reticulum.

Additionally, KCTD21-AS1 has been shown to interact with several other proteins, including the transcription factor, NF-kappa-B, and the protein kinase, p300. This interaction with these proteins suggests that KCTD21-AS1 may be involved in the regulation of cellular processes such as cell signaling, inflammation, and metabolism.

Another potential function of KCTD21-AS1 is its role in the development and progression of certain diseases. For example, KCTD21-AS1 has been shown to be overexpressed in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This overexpression may contribute to the development and progression of these diseases, making KCTD21-AS1 a potential target for new therapies.

In addition to its potential as a drug target or biomarker, KCTD21-AS1 also has interesting structural features that may make it a useful structural protein for studies of protein structure and function. The unique arrangement of the amino acid residues in KCTD21-AS1, as well as its calculated molecular weight, suggest that it may have a unique structure that could be useful for studies of protein structure and stability.

Overall, KCTD21-AS1 is a protein with interesting structural and functional features that may make it a useful drug target or biomarker. Further research is needed to fully understand its role in cellular processes and its potential as a therapeutic agent.

Protein Name: KCTD21 Antisense RNA 1

The "KCTD21-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCTD21-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets